SS Innovations International, Inc. (NASDAQ: SSII) announced that it has been named the winner of the Outstanding Company category at the 2026 Surgical Robotics Industry Awards. The award recognizes a company demonstrating excellence in innovation, commercial success, industry leadership and positive societal impact. According to the company, the award reflects the growing adoption of its SSi Mantra surgical robotic system, which it believes is gaining traction for its advanced technology, user-friendly design, training capabilities and cost efficiency.
As of June 22, 2026, SS Innovations reported that 11,719 multi-specialty procedures had been performed using the SSi Mantra system, including 612 cardiac procedures, 175 telesurgeries and 212 pediatric surgeries. The company also said approximately 2,100 physicians have been trained on the platform, which has been used for more than 170 procedure types and has received regulatory approval in 14 countries. The award highlights the company's progress in making robotic surgery more accessible globally.
For more details, the full press release is available at https://ibn.fm/XWdRe.
SS Innovations International, Inc. (NASDAQ: SSII) develops innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a larger segment of the global population. The company's product range includes its proprietary SSi Mantra surgical robotic system and its comprehensive suite of SSi Mudra surgical instruments, which support a variety of surgical robotic procedures including cardiac surgery. An American company headquartered in India, SS Innovations plans to expand the global presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions. More information is available on the company's website at ssinnovations.com.
This recognition comes at a time when the surgical robotics industry is rapidly evolving, and SS Innovations' achievement underscores its role as a key player in advancing robotic surgery worldwide. The company's focus on affordability and training could help bridge the gap in access to advanced surgical care in underserved regions.
